Showing results (331-340 of 370) with videos related to
Sort By:
Pageof 37
Clinical Chemistry|December 23, 2006
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancerThomas Steuber, Andrew J Vickers, Angel M Serio, et al.Endocrinology|October 1, 1993
Natriuretic hormone receptors and actions on bone endothelial cellsM L De Feo, F Franceschelli, U Frediani, et al.British Journal of Cancer|September 14, 2006
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cellsI Cellai, S Benvenuti, P Luciani, et al.The Journal of Biological Chemistry|January 14, 2001
Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytesA Bonacchi, P Romagnani, R G Romanelli, et al.Journal of Endocrinological Investigation|November 13, 2007
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cellsS Benvenuti, I Cellai, P Luciani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened populationDavid Ulmert, Angel M Serio, Matthew F O'Brien, et al.Journal of Cellular and Molecular Medicine|January 16, 2008
Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol contentC Cecchi, F Rosati, A Pensalfini, et al.Proceedings of the National Academy of Sciences of the United States of America|November 29, 2007
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeXingxing Zang, R Houston Thompson, Hikmat A Al-Ahmadie, et al.International Journal of Cancer|November 4, 2000
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factorA Peri, L Bonaccorsi, M Muratori, et al.The Journal of Endocrinology|July 10, 2008
Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1)S Giannini, S Benvenuti, P Luciani, et al.Pageof 37